States Advance Marijuana and Psychedelics for First Responder PTSD Treatment

Multiple U.S. states are expanding access to cannabis and psychedelic therapies to treat post-traumatic stress disorder (PTSD) among first responders, including firefighters, law enforcement, and military personnel. First responders accumulate significant psychological trauma from repeated exposure to traumatic events, necessitating innovative therapeutic approaches beyond traditional counseling. These legislative efforts recognize that cannabis and psychedelics, particularly psilocybin and MDMA, show promising clinical outcomes in treating PTSD symptoms including hypervigilance, intrusive memories, and emotional dysregulation. The expansion represents a significant policy shift acknowledging both the mental health crisis among first responders and the evidence supporting cannabinoid and psychedelic-assisted therapies. This development is particularly relevant for Puerto Rico's first responder communities seeking comprehensive mental health treatment options.